Evidence map›Paper›PMID 40707618›Full record

ArticleScientific reports2025

The in vitro potential of non-thermal atmospheric pressure plasma against Nosema ceranae infection in honeybees (Apis mellifera).

Thummanoon Boonmee, Chainarong Sinpoo, Kasidet Laokulsiri, Gaokaew Piyaphonsakon, Kamonporn Panngom, Terd Disayathanoowat, Jeffery S Pettis, Veeranan Chaimanee

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thummanoon Boonmee *Department of Agro-Industrial Biotechnology, Maejo University Phrae Campus, Phrae, 54140, Thailand.
Chainarong Sinpoo *Bee Protection Laboratory, Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, 50200, Thailand.
Kasidet LaokulsiriDepartment of Agro-Industrial Biotechnology, Maejo University Phrae Campus, Phrae, 54140, Thailand.
Gaokaew PiyaphonsakonDepartment of Agro-Industrial Biotechnology, Maejo University Phrae Campus, Phrae, 54140, Thailand.
Kamonporn PanngomBasic Science, Maejo University Phrae Campus, Phrae, 54140, Thailand.
Terd DisayathanoowatBee Protection Laboratory, Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, 50200, Thailand.
Jeffery S PettisPettis and Assoc. LLC, Salisbury, MD, 21801, USA.
Veeranan ChaimaneeDepartment of Agro-Industrial Biotechnology, Maejo University Phrae Campus, Phrae, 54140, Thailand. chveeranan@gmail.com.

Funding

CMU Proactive Researcher, Chiang Mai University 757/2567Thailand Science Research and Innovation and Maejo University, Thailand MJU.1-66-06-005
6 · The paper itself

Abstract

Nosema ceranae is a widespread microsporidian parasite that primarily affects adult honeybees (Apis mellifera) but has also been reported to infect honeybee larvae. It has been considered as a main cause of colony losses. This study evaluated the anti-microsporidian activity of atmospheric non-thermal plasma against N. ceranae, which could provide a new technology for controlling Nosema disease. Argon and helium plasma substantially decreased N. ceranae spores, with the maximal reductions of 96.55% and 96.05%, respectively. Also, plasma activated water (PAW) generated by argon gas affected spores by a 50.51-77.14% of reduction, with H

Indexed as

MicrosporidiosisNosemaPlasma GasesAnimalsArgonBeesHeliumHydrogen PeroxideSpores, FungalArgonHeliumHydrogen PeroxidePlasma GasesAnti-microsporidian activityHoneybeesNon-thermal atmospheric pressure plasmaNosema ceranaePlasma-activated water

Identifiers

PMID40707618
PMCPMC12290067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.